|
Mechanismβ1-adrenergic receptor antagonists |
|
|
|
|
Drug Highest PhaseApproved |
First Approval Ctry. / Loc.JP |
First Approval Date05 Jul 2002 |
100 Clinical Results associated with Trimedica Ltd.
0 Patents (Medical) associated with Trimedica Ltd.
100 Deals associated with Trimedica Ltd.
100 Translational Medicine associated with Trimedica Ltd.